Jazz Pharmaceuticals plc — Director's Dealing 2022

Aug 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-08-05

Reporting Person: RIEDEL NORBERT G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-05	Ordinary Shares	M	8000	$55.28	Acquired	18399	Direct
2022-08-05	Ordinary Shares	S	8000	$155.865	Disposed	10399	Direct
2022-08-05	Ordinary Shares	A	2561	$0.0	Acquired	12960	Direct
2022-08-08	Ordinary Shares	S	1089	$152.3204	Disposed	11871	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-05	Non-Qualified Stock Option (right to buy)	$55.28	M	8000	Disposed	2023-05-08	Ordinary Shares (8000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.80.00 to $156.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F2: These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023.

F3: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

F4: This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter.